Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
Authors:
- Martine BerliereMBMartine Berliere
- Florence DalencFDFlorence Dalenc
- Nathalie MalingretNMNathalie Malingret
- Anita VindevogelAVAnita Vindevogel
- Philippe PiettePPPhilippe Piette
- Henry RocheHRHenry Roche
- Jacques DonnezJDJacques Donnez
- Michel SymannMSMichel Symann
- Joseph KergerJKJoseph Kerger
- Jean-Pascal MachielsJMJean-Pascal Machiels
Open Access
- 21 February 2008
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 56
Abstract
To determine the incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.Keywords
This publication has 30 references indexed in Scilit:
- The effects of paclitaxel, dose density, and trastuzumab on treatment‐related amenorrhea in premenopausal women with breast cancerCancer, 2010
- Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 TrialJournal of Clinical Oncology, 2006
- Identifying menopause in breast cancer patients: considerations and implicationsBreast Cancer Research and Treatment, 2006
- Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneCancer, 2005
- Chemotherapy-induced amenorrhea in early breast cancerAnnals of Oncology, 2005
- Premature ovarian failureMolecular and Cellular Endocrinology, 2000
- II.1 Tamoxifen's oestrogen-like effects in a breast cancer chemoprevention trialEuropean Journal of Cancer, 1998
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- MECHANISM OF ACTION OF ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCERThe Lancet, 1986
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCERThe Lancet, 1983